Speaker Abstracts

	Symposium 6. DIABETES MELLITUS IN ETHNIC GROUPS, 1330-1520, June 4
	Prevalence and Impact of Diabetes in a Canadian Native Community: The Sandy Lake Health and Diabetes Project Bernard Zinman, MDCM and Stewart Harris, MD, SLRI, Mount Sinai Hospital, U of T, Toronto M5G 1X5.
	Diabetes and Cardiovascular Disease in Hispanic and Native Americans in the U. S. Michael P. Stern, University of Texas Health Science Center, San Antonio, TX.
	Premature Coronary Artery Disease (CAD) Is a Major Public Health Problem for Asian Indians Prakash C. Deedwania, VACCHCS, Fresno, CA; UCSF School of Medicine, San Francisco, CA, USA.
	Symposium 9. LIPIDS AND LIPOPROTEINS, 1530-1720, June 4
	Role of Omega-3 Fatty Acids and Heart Health Bruce I Holub, Univ.of Guelph, ON Canada N1G 2W1.
	Symposium 10. HYPERTENSION MANAGEMENT IN DIABETES, 0800-0950, June 5
	Hypertension, Its Management and Outcomes S George Carruthers MD, London Health Sciences Centre and the University of Western Ontario, London, Ontario, Canada N6A 4G5.
	The Effect of Hypertension on Diabetes Outcomes Ellen Burgess, University of Calgary, Calgary T2N 2T9.
	Insulin and Endothelial Function: Diabetes and Hypertension J. H. McNeill, Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, B.C. V6T 1Z3.
	Cost Effectiveness of Blood Pressure Monitoring and Control Arun Chockalingam, Manager, Dissemination and Professional Liaison Section, Adult Health Division, Health Canada, Ottawa, Ontario, Canada K1A 1B4.
	Symposium 14. OBESITY, DIABETES AND CARDIOVASCULAR RISK, 0800-0950, June 6
	Reducing the Risk of Cardiovascular Disease in People with Type 2 Diabetes F. Xavier Pi-Sunyer, St. Luke's-Roosevelt Hospital Center, Columbia U., New York, N.Y. 10025.
	Obesity and Insulin Resistance: Insights from Adipose Cell Biology David C. W. Lau, Edith Aziz, Gillian Shillabeer and James C. Russell, Dept. of Med. & Loeb Res. Inst., Univ. of Ottawa, Ottawa, ON, K1Y 4E9.
	Insulin resistance and Lipoprotein Metabolism Gary F. Lewis, University of Toronto, Toronto, CA, M5G 2C4.
	The Insulin Resistance Syndrome of Abdominal Obesity: Clinical and Public Health Implications Beyond the Prevention of Type 2 Diabetes J.-P. Després, Ph.D., Québec Heart Institute and Lipid Research Center, CHUL Research Center, Sainte-Foy, CANADA.
	Symposium 16. THE CANADIAN HEART HEALTH INITIATIVE, 0800-0950, June 6
	Heart Health Dissemination: Scientific and Practical Knowledge from the Canadian Experience D. Harvey, Manitoba Heart Health Project, University of Manitoba, Winnipeg, Manitoba R3T 2N2.
	Symposium 17. CANADIAN HEART HEALTH STUDY, 1030-1220, June 6
	Prevalence of Cardiovascular Risk Factors in Canadian Adults with Diabetes Mellitus: The Canadian Heart Health Surveys Michel R. Joffres, David R. MacLean, Mena H. Tan, Andres Petrasovits
	Patterns of Glycosylated Hemoglobin and Fasting Plasma Glucose in a Population with Diagnosed and Non-Diagnosed Diabetes Dale E. Gelskey and Robert Tate, University of Manitoba R3T 2N2.
	Relationship of Plasma apolipoproteins AI and B and Diabetes in the Canadian Heart Health Survey Philip W. Connelly, Ph.D., St. Michael's Hospital, Toronto, ON Canada M5B 1A6.
	HEALTH POLICY FORUM, 1330-1520, June 6
	Putting Policy Into Action Sharon M. Macdonald, MD, FRCPC
	National and International Strategies in the Prevention of Obesity and Diabetes Bruce A. Reeder, University of Saskatchewan, S7N 5E5.
	The Diabetes Council of Canada (DCC): Co-ordinating National Diabetes Strategies N.W. Rodger, MD, Chair, DCC, University of Western Ontario, London, Ontario, N6A 4V9.
	Federal Role in Health: Canadian Diabetes Prevention and Control Strategy Wm. Phillip Mickelson, Senior Medical Advisor, NCD Prevention and Control Section, Adult Health Division, Health Canada, Ontario, Canada K1A 1B4.
	Diabetes: A Manitoba Strategy From Policy to Action Noella L. Depew, RN, BA
	Government and Community: The Aboriginal Diabetes Initiative Alexa Brewer